Characteristics of antidepressant medication users in a cohort of mid-age and older Australians

Australian and New Zealand Journal of Psychiatry

Volumn 49, Issue 3, 2015, Pages 275-290

  Paige, Ellie ^a   Korda, Rosemary J ^a   Kemp, Anna ^b   Rodgers, Bryan ^c   Banks, Emily ^a,d  

^a The Australian National University   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^d SAX INSTITUTE   (Australia)

Author keywords

Antidepressant medication; cohort studies; population studies

Indexed keywords

ANTIDEPRESSANT AGENT; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ANXIETY; ARTICLE; AUSTRALIAN; COHORT ANALYSIS; DEMOGRAPHY; DEPRESSION; DISEASE PREDISPOSITION; DISTRESS SYNDROME; DRUG CLASSIFICATION; DRUG MEGADOSE; DRUG USE; EDUCATIONAL STATUS; FEMALE; HUMAN; INCOME; LIFESTYLE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MIDDLE AGED; OBESITY; PHYSICAL ACTIVITY; PHYSICAL DISEASE; PRIVATE HEALTH INSURANCE; SELF REPORT; SEX DIFFERENCE; SMOKING; SOCIAL STATUS; UNDERWEIGHT; VERY ELDERLY; AUSTRALIA; DRUG UTILIZATION; HEALTH STATUS; RISK FACTOR; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; AUSTRALIA; COHORT STUDIES; DRUG UTILIZATION; FEMALE; HEALTH STATUS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84923345040     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867414560653     Document Type: Article

References (42)

1. Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability. Journal of Affective Disorders. 2000 ; 58: 19-36
2. Andersen R, Newman JF. Societal and individual determinants of medical care utilization in the United States. The Milbank Memorial Fund Quarterly Health and Society. 1973 ; 51: 95-124
3. Andersen R, Newman JF. Societal and individual determinants of medical care utilization in the United States. The Milbank Quarterly. 2005 ;: 83
4. Andrade SE, Kahler KH, Frech F, et al. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiology and Drug Safety. 2006 ; 15: 565-574
5. Australian Bureau of Statistics (2006) 4824.0.55.001 - Mental Health in Australia: A Snapshot, 2004-05. Available at: www.abs.gov.au/ausstats/abs@nsf/mf/4824.0.55.001.
6. Australian Bureau of Statistics (2008) 4326.0 - National Survey of Mental Health and Wellbeing: Summary of Results, 2007. Available at: www.abs.gov.au/AUSSTATS/abs@nsf/Latestproducts/4326.0Main%20Features32007?opendocument&tabname=Summary&prodno=4326.0&issue=2007&num=&view=.
7. Australian Bureau of Statistics (2013) 4125.0 - Gender Indicators, Australia, Jan 2013: mental health. Available at: www.abs.gov.au/ausstats/abs@nsf/Lookup/by%20Subject/4125.0∼Jan%202013∼Main%20Features∼Mental%20health∼3150.
8. Canberra: AIHW ; 2003 :
9. Canberra: AIHW ; 2004 :
10. Banks E, Byles JE, Gibson RE, et al. Is psychological distress in people living with cancer related to the fact of diagnosis, current treatment or level of disability? Findings from a large Australian study. Medical Journal of Australia. 2010 ; 193: S62 - S67
11. Banks E, Redman S, Jorm L, et al. Cohort profile: The 45 and up study. International Journal of Epidemiology. 2008 ; 37: 941-947
12. Blazer DG, Hybels CF, Fillenbaum GG, et al. Predictors of antidepressant use among older adults: Have they changed over time?. American Journal of Psychiatry. 2005 ; 162: 705-710
13. Blazer DG, Hybels CF, Simonsick EM, et al. Marked differences in antidepressant use by race in an elderly community sample: 1986-1996. American Journal of Psychiatry. 2000 ; 157: 1089-1094
14. Brown SL, Salive ME, Guralnik JM, et al. Antidepressant use in the elderly: Association with demographic characteristics, health-related factors, and health care utilization. Journal of Clinical Epidemiology. 1995 ; 48: 445-453
15. Byles JE, Robinson I, Banks E, et al. Psychological distress and comorbid physical conditions: Disease or disability?. Depression and Anxiety. 2014 ; 31: 524-532
16. Department of Health and Ageing (2013) About the PBS. Available at: www.pbs.gov.au/info/about-the-pbs.
17. Eaddy MT, Druss BG, Sarnes MW, et al. Relationship of total health care charges to selective serotonin reuptake inhibitor utilization patterns including the length of antidepressant therapy - results from a managed care administrative claims database. Journal of Managed Care Pharmacy. 2005 ; 11: 145-150
18. Ganguli M, Mulsant B, Richards S, et al. Antidepressant use over time in a rural older adult population: The MoVIES project. Journal of the American Geriatrics Society. 1997 ; 45: 1501-1503
19. Goldney RD, Taylor AW, Bain MA. Depression and remoteness from health services in South Australia. Australian Journal of Rural Health. 2007 ; 15: 201-210
20. Grunebaum MF, Oquendo MA, Manly JJ. Depressive symptoms and antidepressant use in a random community sample of ethnically diverse, urban elder persons. Journal of Affective Disorder. 2008 ; 105: 273-277
21. Harris MG, Burgess PM, Pirkis J, et al. Correlates of antidepressant and anxiolytic, hypnotic or sedative medication use in an Australian community sample. Australian and New Zealand Journal of Psychiatry. 2011 ; 45: 249-260
22. Hollingworth SA, Burgess PM, Whiteford HA. Affective and anxiety disorders: Prevalence, treatment and antidepressant medication use. Australian and New Zealand Journal of Psychiatry. 2010 ; 44: 513-519
23. Karkare SU, Bhattacharjee S, Kamble P, et al. Prevalence and predictors of antidepressant prescribing in nursing home residents in the United States. American Journal of Geriatric Pharmacotherapy. 2011 ; 9: 109-119
24. Kessler RC, Andrews G, Colpe LJ, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychological Medicine. 2002 ; 32: 959-976
25. Kivimaki M, Gunnell D, Lawlor DA, et al. Social inequalities in antidepressant treatment and mortality: A longitudinal register study. Psychological Medicine. 2007 ; 37: 373-382
26. Maher AR, Theodore G. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics. Journal of Managed Care Pharmacy. 2012 ; 18: S1 - S20
27. Mealing NM, Banks E, Jorm LR, et al. Investigation of relative risk estimates from studies of the same population with contrasting response rates and designs. BMC Medical Research Methodology. 2010 ; 10: 26
28. Health at a Glance 2013: OECD Indicators. OECD Publishing ; 2013 :
29. Page AN, Swannell S, Martin G, et al. Sociodemographic correlates of antidepressant utilisation in Australia. Medical Journal of Australia. 2009 ; 190: 479-483
30. Papakostas GI, Shelton RC, Smith J, et al. Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: A meta-analysis. Journal of Clinical Psychiatry. 2007 ; 68: 826-831
31. Pfeiffer PN, Glass J, Austin K, et al. Impact of distance and facility of initial diagnosis on depression treatment. Health Services Research Journal. 2011 ; 46: 768-786
32. Power C, Rodgers B, Hope S. U-shaped relation for alcohol consumption and health in early adulthood and implications for mortality. Lancet. 1998 ; 352: 877
33. Sax Institute (2014) Secure Unified Research Environment. Available at: www.sure.org.au/.
34. Schoen C, Osborn R, Huynh PT, et al. Primary care and health system performance: Adults' experiences in five countries. Health Affairs (Millwood). 2004 ;: 487-503
35. Sclar DA, Robison LM, Skaer TL, et al. Antidepressant prescribing patterns - A comparison of blacks and whites in a Medicaid population. Clinical Drug Investigation. 1998 ; 16: 135-140
36. Soudry A, Dufouil C, Ritchie K, et al. Factors associated with antidepressant use in depressed and non-depressed community-dwelling elderly: The three-city study. International Journal of Geriatric Society. 2008 ; 23: 324-330
37. Statabase Reference Manual Release 12. Texas: Stata Press ; 2011 :
38. Stewart AL, Ware JE Measuring functioning and well-being: The medical outcomes study approach. Duke University Press ; 1992 :
39. Guidelines for ATC classification and DDD assignment 2013. Oslo: WHO ; 2012 :
40. World Health Organization Collaborating Centre for Drug Statistics Methodology (2013) ATC stucture and principles. Available at: www.whocc.no/atc/structure-and-principles/.
41. Zhang Y, Chow V, Vitry AI, et al. Antidepressant use and depressive symptomatology among older people from the Australian Longitudinal Study of Ageing. International Psychogeriatrics. 2010 ; 22: 437-444
42. Zimmerman M, Posternak M, Friedman M, et al. Which factors influence psychiatrists' selection of antidepressants?. American Journal of Psychiatry. 2004 ; 161: 1285-1289